Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2764622A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010CA2764141A1 Heterocyclic antiviral compounds
12/16/2010CA2764027A1 Compounds useful for treating premature aging and in particular progeria
12/16/2010CA2764026A1 Compounds useful for treating aids
12/16/2010CA2764024A1 Compounds useful for treating cancer
12/16/2010CA2763717A1 Pyrimidine derivatives as zap-70 inhibitors
12/16/2010CA2737601A1 Anti-viral compounds
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261224A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/15/2010EP2261223A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261214A1 Compounds useful to treat premature aging and in particular progeria
12/15/2010EP2261213A1 Heterocyclic compound
12/15/2010EP2261212A2 Preparation of quinoline-substituted carbonate and carbamate derivatives
12/15/2010EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2260030A2 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
12/15/2010EP2260026A1 Quinazolinone derivatives as tubulin polymerization inhibitors
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP2259689A1 Flavor molecules
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1501822B1 Phthalazinone derivatives
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010CN1993324B 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1882567B Quinazoline derivatives as tyrosine kinase inhibitors
12/15/2010CN101918391A Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
12/15/2010CN101918390A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
12/15/2010CN101918371A Amide derivatives as sirtuin modulators
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101918361A 哌啶磺酰胺衍生物 Piperidine sulfonamide derivative
12/15/2010CN101918360A Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
12/15/2010CN101914090A Method for preparing levo-omeprazole
12/15/2010CN101914089A Anthranilamide pesticide
12/15/2010CN101914088A Piperidine compounds and pharmaceutical compositions containing them
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/15/2010CN101914040A Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
12/15/2010CN101475561B Method for synthesizing pantoprazole and salt thereof
12/15/2010CN101141959B 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
12/15/2010CN100999517B Pyrazole formylamine derivate, its pharmaceutical composition and preparation process
12/14/2010US7853026 Digital sound processing system for a vehicle
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851632 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation
12/14/2010US7851631 Biphenyl compounds useful as muscarinic receptor antagonists
12/14/2010US7851630 Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
12/14/2010US7851625 Process for preparing 2,3-disubstituted indoles
12/14/2010US7851490 1-{1-[3-(2-Methoxy-pyridin-3-yl)-phenyl]-1 H-benzoimidazol-5-yl}-ethylamine, useful in the treatment of central nervous system diseases and disorders, and in particular for combating anxiety; anxiolytic agents
12/14/2010US7851489 N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide; Met kinase inhibitor; hypatocyte growth factor antagonist; anticarcinogenic agent
12/14/2010US7851473 fatty acid amide hydrolase inhibitors such as N-(2-Chlorophenyl)-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide, used for the prophylaxis of brain, psychological or sleep disorders, as neuroprotectants, analgesics, antidepressants or anxiolytic agents
12/14/2010US7851464 Spirolactam aryl CGRP receptor antagonists
12/14/2010US7851463 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
12/14/2010US7851071 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
12/14/2010CA2624847C Dermatitis treating agent
12/14/2010CA2586175C Anticancer compound and enantiomer separation method useful for synthesizing said compound
12/14/2010CA2575718C Salts of benzimidazole derivative with amines and process for manufacturing the same
12/14/2010CA2499125C An improved process for the production of desloratadine
12/14/2010CA2485542C Process for production of phenoxy-substituted 2-pyridone compounds
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2449769C S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2391274C Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141809A1 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010141600A2 Improved method for synthesizing pirfenidone
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010141406A2 Amino pyrimidine anticancer compounds
12/09/2010WO2010141331A2 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
12/09/2010WO2010141074A2 O-glcnac transferase inhibitors and uses thereof
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140092A1 L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
12/09/2010WO2010139967A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/09/2010WO2010139966A1 Azole derivatives as wtn pathway inhibitors
12/09/2010WO2010139953A1 Compounds
12/09/2010WO2010139266A1 Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and intermediates thereof
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010104314A3 Method for preparing non-crystalline (+)-lansoprazole and (+)-lansoprazole alcoholate used in same
12/09/2010WO2009127944A8 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
12/09/2010US20100311979 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/09/2010US20100311972 Method for producing phenoxypyridine derivative
12/09/2010US20100311971 Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
12/09/2010US20100311794 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/09/2010US20100311792 Benzenesulfonamide Compounds and the Use Thereof
12/09/2010US20100311789 3-Substituted Propanamine Compounds
12/09/2010US20100311776 Novel sEH Inhibitors and their Use
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311773 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
12/09/2010US20100311769 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 1080